TY - JOUR
T1 - Oxygen availability in a HAPE-positive and a HAPE-negative woman before and during a visit to 3480 meters
AU - Kleinsasser, Axel
AU - Treml, Benedikt
AU - Burtscher, Johannes
AU - Podolsky, Andrea
AU - Burtscher, Martin
N1 - Publisher Copyright:
© 2020
PY - 2020/10
Y1 - 2020/10
N2 - BACKGROUND: Testing the hypoxic ventilatory response (HVR) at low-altitude helps to detect those who do not hyperventilate appropriately in hypoxia but might not necessarily predict the HVR and the risk to develop acute mountain sickness (AMS) at high altitude. However, a low HVR seems to be particularly prevalent in individuals susceptible to high-altitude pulmonary edema (HAPE+). In this short communication, we assessed differences in physiological parameters in two comparable women before and 3 hours after exposure to 3,480 meters. One woman had a (clinically diagnosed) history of high-altitude pulmonary edema (HAPE+) while the other did well at previous exposures to high altitude (HAPE-).METHODS: Heart rate, blood pressure, ventilation, arterial blood gas variables, arterial haemoglobin saturation, haemoglobin concentration, arterial oxygen content and delta plasma volume were measured or calculated before and after arrival at high altitude.RESULTS: At high altitude, plasma volume decreased in the HAPE- woman which in turn increased haemoglobin concentration. Ventilation was elevated in the HAPE- but not in the HAPE + woman. Arterial oxygen content fell in the HAPE + while it was preserved in the HAPE- woman. This resulted from lower peripheral oxygen saturation (-35%), lower haemoglobin concentration (-12%) and lower arterial partial pressure of oxygen (-59%) in the HAPE+.CONCLUSION: Considerable haemoglobin desaturation and lack of haemoconcentration were characteristics of the HAPE + woman when exposed to high altitude, while the higher arterial oxygen content in the HAPE- woman was related to both haemoconcentration and hyperventilation (and associated haemoglobin saturation).
AB - BACKGROUND: Testing the hypoxic ventilatory response (HVR) at low-altitude helps to detect those who do not hyperventilate appropriately in hypoxia but might not necessarily predict the HVR and the risk to develop acute mountain sickness (AMS) at high altitude. However, a low HVR seems to be particularly prevalent in individuals susceptible to high-altitude pulmonary edema (HAPE+). In this short communication, we assessed differences in physiological parameters in two comparable women before and 3 hours after exposure to 3,480 meters. One woman had a (clinically diagnosed) history of high-altitude pulmonary edema (HAPE+) while the other did well at previous exposures to high altitude (HAPE-).METHODS: Heart rate, blood pressure, ventilation, arterial blood gas variables, arterial haemoglobin saturation, haemoglobin concentration, arterial oxygen content and delta plasma volume were measured or calculated before and after arrival at high altitude.RESULTS: At high altitude, plasma volume decreased in the HAPE- woman which in turn increased haemoglobin concentration. Ventilation was elevated in the HAPE- but not in the HAPE + woman. Arterial oxygen content fell in the HAPE + while it was preserved in the HAPE- woman. This resulted from lower peripheral oxygen saturation (-35%), lower haemoglobin concentration (-12%) and lower arterial partial pressure of oxygen (-59%) in the HAPE+.CONCLUSION: Considerable haemoglobin desaturation and lack of haemoconcentration were characteristics of the HAPE + woman when exposed to high altitude, while the higher arterial oxygen content in the HAPE- woman was related to both haemoconcentration and hyperventilation (and associated haemoglobin saturation).
KW - Altitude Sickness/blood
KW - Blood Pressure/physiology
KW - Female
KW - Heart Rate/physiology
KW - Hemoglobins/metabolism
KW - Humans
KW - Hypertension, Pulmonary/blood
KW - Hyperventilation/blood
KW - Oxygen/blood
KW - Respiratory Physiological Phenomena
KW - High altitude
KW - HAPE
KW - Arterial oxygen content
UR - http://www.scopus.com/inward/record.url?scp=85088860632&partnerID=8YFLogxK
U2 - 10.1016/j.resp.2020.103513
DO - 10.1016/j.resp.2020.103513
M3 - Letter/short communication
C2 - 32745709
SN - 1569-9048
VL - 281
SP - 103513
JO - Respiratory Physiology and Neurobiology
JF - Respiratory Physiology and Neurobiology
M1 - 103513
ER -